In 2018, the World Health Organization (WHO) established the Strategic Advisory Group of Experts on In Vitro Diagnostics (SAGE IVD) to act as an advisory body
to matters of global policies and strategies related to in vitro diagnostics (IVDs). The SAGE IVD is expected to meet every two years to make recommendations on the content, format, and implementation of the WHO model list of essential in vitro diagnostics (EDL) and on any matters related to IVDs.
Declarations of Interests
WHO Secretariat has received and assessed all the DOIs submitted by the participating experts. In accordance with WHO's policy, all declared interests, even if they do not give rise to a conflict of interest that would warrant partial or total exclusion of the expert concerned, will be disclosed within the Committee at the beginning of the meeting so that other members are aware of them.
Calls
SAGE IVD meetings
SAGE IVD terms of reference
2023 Terms of Reference for Strategic Advisory Group of Experts on In Vitro Diagnostics (SAGE IVD)
The document describes the application process, roles and expectations of the members of SAGE IVD. This is a revised version as of March 2023. This version...
2021 Terms of Reference for Strategic Advisory Group of Experts on In Vitro Diagnostics (SAGE IVD)
The document describes the application process, roles and expectations of the members of SAGE IVD. This is a revised version as of December 2020. This...
2018-2020 Terms of Reference for Strategic Advisory Group of Experts on In Vitro Diagnostics (SAGE IVD)
The following describes the application process, roles and expectations of the members of SAGE IVD. This is a revised version as of June 2018. This version...
2025 SAGE IVD panel
Researcher at the National Institute of Infectious Diseases
Director of the National Public Health Laboratory of Nepal
Professor of Medical Microbiology at Vallabhbhai Patel Chest Institute, University of Delhi
Chair of the Department of Microbiology/Parasitology, Haematology, Immunology and Infectious Diseases at the University of Yaoundé I
Director of the Institut Pasteur de Guyane
Professor of Pathology at the University of Colorado School of Medicine and Director of the Department of Pathology and Laboratory Services at Denver Health
Senior IVD Product Specialist at TÜV Rheinland, Germany
Senior Consultant, Department of Anatomical Pathology Singapore General Hospital (SGH)
Senior Advisor/Senior Research Fellow on Healthcare Policy at the Economic Research Institute for ASEAN and East Asia - Healthcare Unit
Quality Assurance Specialist – IVDs & Medical Laboratory of United Nations Development Programme (UNDP), Gaborone, Botswana
Associated Director at the Instituto de Analises Clínicas de Santos Brazil
Senior Consultant Health Systems Strenghtening
Head of Reference Laboratory, Ministry of Health and Medical Education Iran
Chief Scientist at the Global Health Impact Group
Senior Research Fellow in Health Economics and Decision Science at the University of Sheffield
Previous SAGE IVD panels
2023 SAGE IVD panel
2021 SAGE IVD panel
2020 SAGE IVD panel
2019 SAGE IVD panel
2018 SAGE IVD panel
Publications
All →Technical specifications for selection of essential in vitro diagnostics for SARS-CoV-2
NOTE: This publication is under review and a new version will be published during the third quarter of 2022. Technical specifications for in vitro diagnostics...
Report of the third meeting of the WHO Strategic Advisory Group of Experts on In Vitro Diagnostics, 2020 (including the third WHO model list of essential...
The selection and use of essential in vitro diagnostics: WHO technical report series;1022
The report of the second meeting of the Strategic Advisory Group of Experts on In Vitro was launched in November 2019 and includes the updated WHO Model...
Second WHO Model List of Essential In Vitro Diagnostics
This document is intended to provide a convenient reference to the second edition of the WHO Model List of Essential In Vitro diagnostics (EDL). The EDL...
First WHO model list of essential in vitro diagnostics
The three strategic priorities of WHO stated in its Thirteenth General Programme of Work 2019–2023 are to advance universal health coverage, address...